• Cy5 Goat Anti-Mouse IgG (H+L) Antibody: Fluorescence Amplifi

  2026-06-17

  Unlock the full potential of fluorescence-based immunoassays using the Cy5 Goat Anti-Mouse IgG (H+L) Antibody. Discover stepwise protocol enhancements, advanced use-cases, and troubleshooting strategies that deliver robust, high-sensitivity mouse IgG detection across IHC, ICC, and flow cytometry workflows.

• Kanamycin Sulfate: Engineered Precision for Translational Re

  2026-06-17

  Explore the mechanistic, experimental, and translational dimensions of Kanamycin Sulfate as a water-soluble antibiotic for next-generation microbiology and anti-infection research. Anchored by recent advances in circular RNA purification and antibiotic resistance workflows, this thought-leadership article provides actionable insights for translational researchers—bridging rigorous mechanistic rationale with strategic guidance and workflow optimization. Discover how APExBIO’s high-purity Kanamycin Sulfate (SKU A2516) empowers reproducibility, precision, and innovation beyond conventional product overviews.

• Structural Mechanisms of CD38 Engagement and CAR Affinity Tu

  2026-06-16

  This article analyzes a recent iScience study that reveals the structural basis for CD38 antigen recognition by CAR binders and demonstrates rational affinity tuning to optimize selectivity and function in CAR-T cell therapy. The findings provide a framework for designing safer, more effective CD38-targeted immunotherapies and inform best practices for integrating cell viability assays in translational workflows.

• Angiotensin I: Experimental Workflows for Cardiovascular Res

  2026-06-16

  Angiotensin I (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu) enables precise, reproducible modeling of the renin-angiotensin system and supports advanced antihypertensive drug screening. This article provides actionable workflows, troubleshooting strategies, and insight into novel research applications using APExBIO’s rigorously characterized decapeptide.

• Toremifene in Breast Cancer: 20 Years of Clinical Evidence

  2026-06-15

  This review synthesizes two decades of clinical data on toremifene, a selective estrogen receptor modulator (SERM), for hormone-sensitive breast cancer. The findings clarify its efficacy, safety, and clinical positioning relative to aromatase inhibitors, guiding precision endocrine therapy decisions.

• Topotecan HCl: Optimizing Topoisomerase 1 Inhibitor Workflow

  2026-06-15

  Topotecan HCl stands as a benchmark topoisomerase 1 inhibitor, enabling robust DNA damage and apoptosis assays in cancer research. This guide details advanced experimental workflows, troubleshooting strategies, and protocol enhancements for maximizing its antitumor efficacy in preclinical settings.

• TG003 Cdc2-like Kinase Inhibitor: Precision Tools for RNA Sp

  2026-06-14

  TG003 stands out as a benchmark Cdc2-like kinase inhibitor for dissecting alternative splicing mechanisms and modeling cancer resistance. Its nanomolar potency, well-characterized selectivity, and robust translational backing enable rigorous experimental control in both basic and disease-oriented RNA research.

• Exosomal SNORD52 Drives M2 Macrophage Polarization via JAK2/

  2026-06-13

  This study reveals that exosomal SNORD52 derived from hepatoma cells induces M2 macrophage polarization by activating the JAK2/STAT6 pathway. The findings illuminate a novel mechanism of tumor-immune modulation in hepatocellular carcinoma and provide a foundation for targeted investigations into the inhibition of JAK-STAT signaling pathways.

• DNA Damage Selectively Depletes CUX2 Neurons in Neuroinflamm

  2026-06-12

  The referenced study uncovers that DNA damage burden underlies the selective vulnerability and loss of CUX2+ upper layer cortical neurons during neuroinflammation, such as that seen in multiple sclerosis. Through the use of both human tissue and diverse mouse models, the research elucidates mechanisms by which impaired DNA repair and inflammatory signaling converge to drive neuron-type-specific degeneration, advancing our understanding of neurodegenerative disease pathogenesis.

• Practical Guide: EdU Flow Cytometry Assay Kits (Cy5) in S-Ph

  2026-06-12

  EdU Flow Cytometry Assay Kits (Cy5) provide a direct, sensitive approach for quantifying cell proliferation by detecting S-phase DNA synthesis without harsh denaturation. This kit is designed for flow cytometry workflows and excels where antibody multiplexing or cell cycle staging is required. It is not intended for fixed-tissue histology or applications outside flow cytometric analysis.

• Selective CUX2 Neuron Loss from DNA Damage in Neuroinflammat

  2026-06-11

  This study reveals that DNA damage burden and insufficient repair mechanisms drive selective loss of CUX2-expressing cortical neurons during neuroinflammation, especially in multiple sclerosis. The findings clarify molecular vulnerabilities underlying region- and cell-type-specific neurodegeneration, offering new mechanistic insights relevant to both neuroscience and DNA damage research.

• EV-Transferred ACLY Drives Immunosuppressive Macrophage Fate

  2026-06-11

  This study reveals that hepatocellular carcinoma (HCC) cells use extracellular vesicles to deliver ATP-citrate lyase (ACLY) into monocytes, driving their differentiation into immunosuppressive tumor-associated macrophages (TAMs). By elucidating the metabolic and molecular mechanisms underpinning TAM education, the research offers new therapeutic avenues for targeting macrophage-driven immune evasion in HCC.

• Strategic Use of Dovitinib (TKI-258) in Translational Oncolo

  2026-06-10

  Dovitinib (TKI-258, CHIR-258) is redefining multitargeted receptor tyrosine kinase inhibition for translational researchers tackling the complexity of oncogenic signal transduction in cancer. This thought-leadership article explores the mechanistic rationale, experimental parameters, and strategic integration of Dovitinib in advanced cancer models—drawing on recent breakthroughs in circRNA biology and actionable workflow guidance, while positioning APExBIO's Dovitinib as a pivotal tool for next-generation oncology research.

• Angiotensin I in Cross-Domain Research: From Cardiovascular

  2026-06-10

  Explore the multifaceted roles of Angiotensin I in cardiovascular and cross-domain research. This in-depth analysis uncovers mechanistic nuances, recent peptide-pathogen insights, and protocol considerations unique to APExBIO's rigorously characterized Angiotensin I (human, mouse, rat).

• Topotecan HCl: Optimizing Topoisomerase 1 Inhibitor Workflow

  2026-06-09

  Harness the power of Topotecan HCl for precise, reproducible antitumor assays, from robust sphere-forming inhibition to advanced cytotoxicity modeling. This guide reveals actionable protocol enhancements, troubleshooting tactics, and the translational impact of DNA damage insights for cancer research.

16160 records 1/1078 page Next 12345 下5页 Last page